![](/images/2013/post-sep.jpg)
Acne Medication Market Size Poised to Hit USD 13.35 Billion by 2027, Driven by a 3.8% CAGR: Insights from AMR
![๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐ก๐๐ฌ ๐ฉ๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐ ๐ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐ญ๐ก๐ ๐ญ๐ข๐ญ๐ฅ๐ ๐๐๐ง๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ฐ๐๐ฌ ๐๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ ๐๐ Acne Medication Market Size, Share 2032](https://img.einnews.com/ampsize/738548/acne-medication-market-size-sh.jpeg)
Acne Medication Market Size, Share 2032
North America dominated the acne medication market with the largest share of 47% in 2023 & Asia Pacific is expected to witness significant growth By 2032
PORTLAND, OR, UNITED STATES, September 11, 2024 /EINPresswire.com/ -- ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐ก๐๐ฌ ๐ฉ๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐ ๐ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐ญ๐ก๐ ๐ญ๐ข๐ญ๐ฅ๐ ๐๐๐ง๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ฐ๐๐ฌ ๐๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐๐ง๐ญ๐ข๐๐ข๐ฉ๐๐ญ๐๐ ๐ญ๐จ ๐๐๐ซ๐ง๐๐ซ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ซ๐๐ ๐ข๐ฌ๐ญ๐๐ซ๐ข๐ง๐ ๐ ๐๐๐๐ ๐จ๐ ๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Acne or acne vulgaris is a skin disease caused due to clogging of hair follicles with dead skin cells and oil from skin cells. This disease is characterized by pimples, blackheads, oily skin, and scarring. There are two types of acne including non-inflammatory and inflammatory acne, where the latter takes longer duration to heal and can cause permanent effects on skin. It generally affects skin with comparatively high number of sweat glands such as upper part of chest, back, and face. Acne medications are drugs that are indicated for treatment of acne. These include several prescription and over-the-counter medicines such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives.
Covid-19 scenario:
โข The majority of the dermatology clinic closed their services since the outbreak of Covid-19 and the number of hospitals and clinics is temporarily converted into Covid-19 centers.
โข After several governments imposed social distancing norms and lockdown across the country, people have shifted toward telemedicine to treat acne diseases.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/4356
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐๐ง๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ?
Increase in prevalence of acne diseases, surge in focus toward good quality skincare products, and unhealthy urban lifestyle drive the growth of the global acne medication market. The market across Asia-Pacific is expected to portray the highest CAGR of 4.9% during the forecast period. After several governments imposed social distancing norms and lockdown across the country, people have shifted toward telemedicine to treat acne diseases.
๐๐จ๐ฉ ๐๐๐ง๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข Pfizer Inc.
โข Johnson & Johnson
โข Sun Pharmaceutical Industries Limited
โข Teva Pharmaceutical Industries Ltd.
โข Mylan N.V.
โข Bausch Health Companies Inc.
โข GlaxoSmithKline Plc (GSK)
โข Galderma S.A
โข Mayne Pharma Group Limited
โข Almirall SA.
๐๐๐ง๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โ
The global acne medication market is segmented on the basis of therapeutic class, formulation, type, acne type, distribution channel, and region. Based on therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. The retinoid segment held the largest share in 2019, accounting for nearly one-third of the market. Moreover, the segment is projected to manifest the highest CAGR of 4.6% during the study period.
On the basis of formulation, the market is classified into topical medications and oral medications. The topical segment is expected to register the highest CAGR of 3.9% during the forecast period. Moreover, the segment dominated in 2019, accounting for four-fifths of the market.
Based on type, the market is categorized into prescription medicines and over-the-counter medicines. On the basis of acne type, the market is divided into non-inflammatory acne and inflammatory acne.
The global acne medication market is analyzed across several regions such as Asia-Pacific, LAMEA, Europe, and North America. The market across Asia-Pacific is expected to portray the highest CAGR of 4.9% during the forecast period. However, the market across North America held the largest share in 2019, accounting for nearly half of the market.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4356
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
![](https://energy.einnews.com/tracking/article.gif?aid=742502358§ion=einpresswire&a=mCncRLXJ7Gq0F59u&i=Ya7kZmQf5kUDlEu9)
Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release